Navigation Links
Charles Hauser, John Vann named to PMG Research Board of Directors
Date:8/7/2014

Winston-Salem, NC (PRWEB) August 07, 2014

PMG Research, Inc. announced today the election of its Board of Directors. Charles Hauser, CEO of Piedmont Stone Center, and John Vann, a business management consultant at The Summit Companies, will join Jennifer Byrne, Chairman of the Board and CEO of PMG Research, and Joel Lanik, Partner at Frontier Capital, as Directors on PMG Research Board.

PMG Research is a network of sites that provide clinical research services to pharmaceutical companies and CROs, with access to 1.7 million patient lives through its partnerships with large physician practices and integrated health systems. PMG Research is comprised of 10 hub site locations in the Southeastern United States and spans 53 physician practices.

“I am pleased to be a member of the PMG Research Board of Directors,” states Charles Hauser. “I look forward to the opportunity to continue to support PMG’s vision and drive for innovation within the clinical trials industry.” From 1980 to 2006, Mr. Hauser was the President and co-founder of Piedmont Medical Research Associates, now PMG Research. He has served on numerous corporate and community Boards, including the State Health Coordinating Council and the North Carolina Medical Care Commission.

John Vann has extensive experience in the clinical research industry, having co-founded Clinical Trial Management Services (CTMS) followed by several years in corporate development with a leading UK-based CRO. “I look forward to participating on the Board of PMG Research. PMG has a reputation for quality and experience, with a strong focus on patient engagement and strategic development that will help define the new landscape in clinical research,” explains Mr. Vann.

“We are grateful for the participation of Mr. Hauser and Mr. Vann on our Board of Directors. They bring an immense breadth of experience and insight, and their guidance will prove valuable as PMG continues to find innovative ways to partner with healthcare, pharma, and CROs to achieve our mission: bringing clinical research to as many lives as possible,” states Jennifer Byrne.

About PMG Research, Inc.
PMG Research, Inc. is an integrated network of clinical research facilities with hub sites located in Cary, Charlotte, Hickory, Raleigh, Salisbury, Wilmington, and Winston-Salem, NC; Charleston, SC; and Bristol and Knoxville, TN. PMG has conducted 7,100 research studies for hundreds of pharmaceutical sponsors and CROs since 1979. We have extensive experience conducting all phases of trials across a comprehensive list of conditions. Our mission is to bring clinical research to as many lives as possible while delivering unparalleled service and exceptional value to our clinical trial partners and stakeholders. To learn more, visit http://www.pmg-research.com.

Read the full story at http://www.prweb.com/releases/2014/08/prweb12076432.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Professor Charles Lieber receives Israels Wolf Prize
2. EMD Millipore Partners with Charles River Laboratories for Improved Viral Clearance Studies
3. BioMed Realty Acquires 320 Charles In Cambridge, MA
4. Elsevier Announces 2013 Library Connect Charleston Conference Award
5. Cleveland Heart Founder Dr. Charles Richardson Appointed to ReliantHeart Board of Directors
6. Charles M. Lieber receives the first Nano Research Award
7. Callibra, Inc. dba Discharge 1-2-3 is Named Winner of 2011 Chicago Innovation Award
8. Dr. Alice Jacobs, CEO of IntelligentMDx, Named Best Entrepreneur in Eighth Annual Stevie® Awards for Women in Business
9. Sequenom Named to NASDAQ Global Select Market
10. U of Toronto experiment named top breakthrough of 2011 by Physics World
11. BioStorage Technologies Mike Reffeitt Named "CFO of the Year" by Indianapolis Business Journal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2017)... Malden, Mass. (PRWEB) , ... May 18, 2017 ... ... completed the procedure on April 28, 2017 at the Prince Of Wales Private ... degenerative cervical disc at level C6-C7. The patient failed conservative treatments prior to ...
(Date:5/18/2017)... ... 2017 , ... NDA Partners Chairman Carl Peck, MD , announced today ... and President of Pharmaceutical Development Business Unit of Cardinal Health, has joined the firm ... he was former Chief Operating Officer at Anaborex, Senior VP and General Manager of ...
(Date:5/18/2017)... ... May 17, 2017 , ... ... business process optimization firm for the life sciences and healthcare industries, is honored ... and Traceability for Medical Devices conference in Brussels, Belgium. , Crowley played a ...
(Date:5/18/2017)... ... May 17, 2017 , ... ... example, are more likely to develop Alzheimer’s disease, while men are at greater ... for this gender-specific neuronal bias is the aim of a research program at ...
Breaking Biology Technology:
(Date:3/30/2017)... March 30, 2017 The research team of ... three-dimensional (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae ... realm of speed and accuracy for use in identification, crime investigation, ... cost. ... A research ...
(Date:3/24/2017)... Controller General of Immigration from Maldives Mr. Mohamed Anwar and ... international IAIR Award for the most innovative high security ePassport and eGates  ... ... Maldives Immigration Controller General, Mr. Mohamed Anwar ... right) have received the IAIR award for the "Most innovative high security ...
(Date:3/22/2017)... , March 21, 2017 ... Cloud used by retailers such as 1-800-Flowers and ... platform — Product Recommendations and Replenishment. Using Optimove,s machine ... more personalized product and replenishment recommendations to their ... also on predictions of customer intent drawn from ...
Breaking Biology News(10 mins):